BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 11948342)

  • 1. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
    Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
    Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology: DNA drives autoimmunity.
    Vinuesa CG; Goodnow CC
    Nature; 2002 Apr; 416(6881):595-8. PubMed ID: 11948338
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
    J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.
    Ahmad-Nejad P; Häcker H; Rutz M; Bauer S; Vabulas RM; Wagner H
    Eur J Immunol; 2002 Jul; 32(7):1958-68. PubMed ID: 12115616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
    Ehlers M; Fukuyama H; McGaha TL; Aderem A; Ravetch JV
    J Exp Med; 2006 Mar; 203(3):553-61. PubMed ID: 16492804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.
    Boulé MW; Broughton C; Mackay F; Akira S; Marshak-Rothstein A; Rifkin IR
    J Exp Med; 2004 Jun; 199(12):1631-40. PubMed ID: 15197227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
    Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
    Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
    Akira S; Hoshino K
    J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
    Schmitz F; Mages J; Heit A; Lang R; Wagner H
    Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling in B cells via Toll-like receptors.
    Peng SL
    Curr Opin Immunol; 2005 Jun; 17(3):230-6. PubMed ID: 15886111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR4, TLR9 and MyD88 are not required for the positive selection of autoreactive B cells into the primary repertoire.
    Silver K; Ferry H; Crockford T; Cornall RJ
    Eur J Immunol; 2006 Jun; 36(6):1404-12. PubMed ID: 16703567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells.
    Yamada M; Oritani K; Kaisho T; Ishikawa J; Yoshida H; Takahashi I; Kawamoto S; Ishida N; Ujiie H; Masaie H; Botto M; Tomiyama Y; Matsuzawa Y
    Eur J Immunol; 2004 Jan; 34(1):221-30. PubMed ID: 14971048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
    Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
    Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIRAP: how Toll receptors fraternize.
    Henneke P; Golenbock DT
    Nat Immunol; 2001 Sep; 2(9):828-30. PubMed ID: 11526396
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of B-cell responses by Toll-like receptors.
    Pasare C; Medzhitov R
    Nature; 2005 Nov; 438(7066):364-8. PubMed ID: 16292312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.
    Honda K; Yanai H; Mizutani T; Negishi H; Shimada N; Suzuki N; Ohba Y; Takaoka A; Yeh WC; Taniguchi T
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15416-21. PubMed ID: 15492225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
    Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T
    Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.